These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 5373063)

  • 1. [Paraneoplastic syndrome in cancer of the prostate].
    Saenz CA; Fredotovich NM
    Rev Argent Urol Nefrol; 1969 Sep; 38(9):139-47. PubMed ID: 5373063
    [No Abstract]   [Full Text] [Related]  

  • 2. [3 cases of prostate cancer metastasis to the cavernous body].
    Bernardi R; Toro J; Giudice C
    Rev Argent Urol Nefrol; 1969 Sep; 38(9):269-70. PubMed ID: 5373089
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of cell-free plasma DNA as a diagnostic marker for prostate cancer.
    Allen D; Butt A; Cahill D; Wheeler M; Popert R; Swaminathan R
    Ann N Y Acad Sci; 2004 Jun; 1022():76-80. PubMed ID: 15251943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening for prostatic cancer].
    Pushkar' DIu; Govorov AV; Bormotin AV
    Urologiia; 2003; (1):10-5. PubMed ID: 12621959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An elevated PSA, which normalizes, does not exclude the presence of prostate cancer.
    Boddy JL; Pike DJ; Al-Hayek S; Shaida N; Malone PR
    Prostate Cancer Prostatic Dis; 2005; 8(4):349-52. PubMed ID: 16010283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The case for prostate cancer screening.
    Andriole GL
    Semin Urol; 1993 May; 11(2):50-3. PubMed ID: 7689738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy?
    Naya Y; Ayala AG; Tamboli P; Babaian RJ
    Urology; 2004 Mar; 63(3):503-8. PubMed ID: 15028446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Present-day possibilities of prostate cancer screening in patients with benign prostatic hyperplasia before and after surgical treatment].
    Pushkar' DIu; Rasner PI; Skobelev PP
    Urologiia; 2001; (6):48-54. PubMed ID: 11785083
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer diagnosis with prostate specific antigen greater than 10 ng./ml. and negative peripheral zone prostate biopsy.
    Fowler JE; Condon MA; Terrell FL
    J Urol; 1996 Oct; 156(4):1370-4. PubMed ID: 8808874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in patients with metastatic (stage D2) prostate cancer: experience from the Scandinavian Prostatic Cancer Group Study-2.
    Jørgensen T; Kanagasingam Y; Kaalhus O; Tveter KJ; Bryne M; Skjørten F; Berner A; Danielsen HE
    J Urol; 1997 Jul; 158(1):164-70. PubMed ID: 9186346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen testing for the early detection of prostate cancer.
    Kirby R; Fitzpatrick J
    BJU Int; 2004 Nov; 94(7):966-7. PubMed ID: 15541108
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimal measure of PSA kinetics to identify prostate cancer.
    Benecchi L; Pieri AM; Destro Pastizzaro C; Potenzoni M
    Urology; 2008 Mar; 71(3):390-4. PubMed ID: 18342170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy].
    Shao Q; Song J; Zhou ZJ; Du LD
    Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small cell prostate cancer with anti-Hu positive peripheral neuropathy.
    Baird AD; Cornford PA; Helliwell T; Woolfenden KA
    J Urol; 2002 Jul; 168(1):192. PubMed ID: 12050524
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of low prostate specific antigen on prostate cancer--a rare case report.
    Schneider HB
    Eur J Med Res; 2007 Jul; 12(7):311-3. PubMed ID: 17933704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Some problems in diagnosing prostatic cancer].
    Riabinskiĭ VS; Chechenin MG; Dem'ianova LA
    Urol Nefrol (Mosk); 1973; 38(5):49-51. PubMed ID: 4782768
    [No Abstract]   [Full Text] [Related]  

  • 17. [Laboratory chemical results in the diagnosis of dermatomyositis].
    Rytter M
    Dtsch Gesundheitsw; 1973 Jan; 28(3):129-33. PubMed ID: 4691917
    [No Abstract]   [Full Text] [Related]  

  • 18. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostate specific antigen and diagnosis of prostate cancer].
    Rigaud J; Bouchot O
    Rev Prat; 2003 Dec; 53(20):2229-36. PubMed ID: 15018076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of extraprostatic extension by prostate specific antigen velocity, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
    Nishimoto K; Nakashima J; Hashiguchi A; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Oya M; Murai M
    Int J Urol; 2008 Jun; 15(6):520-3. PubMed ID: 18422574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.